QA: Acer Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2020_Acer_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001069308, Acer Therapeutics Inc

  xvar xval
0 AssetsCurrent 12,884,996
1 IntangibleAssetsNetIncludingGoodwill 7,647,267
2 PropertyPlantAndEquipmentNet 193,974
3 remainder_Assets 739,274
4 LiabilitiesCurrent 2,768,913
5 LiabilitiesNoncurrent 326,282
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,046,423
9 ResearchAndDevelopmentExpense 13,851,018
10 remainder_Expenses -258
11 remainder_Revenues 0
12 remainder_NetIncome 22,341
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 21,465,511
1 Liabilities 3,095,195
2 Expenses 29,897,183
3 Revenues 0
4 StockholdersEquity 18,370,316
5 NetIncome -29,874,842
6 ComprehensiveNetIncome -29,874,842
7 BaseVar 27,240,115
8 EconomicCapitalRatiobeforeLimitedLiability 0.828
9 EconomicCapitalRatio 2.16

Edgar->Model Mapping

Feature Distribution

Change over Time